Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 6
Encontrada(s) 1 página(s)

Docta Complutense
Publication Artículo científico (JournalArticle)

Increased expression of the ATP-gated P2X7 receptor reduces responsiveness to anti-convulsants during status epilepticus in mice

  • Beamer, Edward
  • Morgan, James
  • Alves, Mariana
  • Menendez Mendez, Aida
  • Morris, Gareth
  • Zimmer, Bela
  • Conte, Giorgia
  • De Diego García, Laura
  • Alarcon Vila, Cristina
  • Yiu Ng, Nico Ka
  • Madden, Stephen
  • Calzaferri, Francesco
  • de los Rios, Cristobal
  • Garcia, Antonio G
  • Hamacher, Michael
  • Dinkel, Klaus
  • Pelegrin, Pablo
  • Henshall, DC
  • Nicke, Annette
  • Engel, Tobias
Background and Purpose: Refractory status epilepticus is a clinical emergency associated with high mortality and morbidity. Increasing evidence suggests neuroinflammation contributes to the development of drug-refractoriness during status epilepticus. Here, we have determined the contribution of the ATP-gated P2X7 receptor, previously linked to inflammation and increased hyperexcitability, to drug refractory status epilepticus and its therapeutic potential. Experimental Approach: Status epilepticus was induced via a unilateral microinjection of kainic acid into the amygdala in adult mice. Severity of status epilepticus was compared in animals with overexpressing or knock-out of the P2X7 receptor, after inflammatory priming by pre-injection of bacterial lipopolysaccharide (LPS) and in mice treated with P2X7 receptor-targeting and anti-inflammatory drugs. Key Results: Mice overexpressing P2X7 receptors were unresponsive to several anticonvulsants (lorazepam, midazolam, phenytoin and carbamazepine) during status epilepticus. P2X7 receptor expression increased in microglia during status epilepticus, at times when responses to anticonvulsants were reduced. Overexpression of P2X7 receptors induced a pro-inflammatory phenotype in microglia during status epilepticus and the anti-inflammatory drug minocycline restored normal responses to anticonvulsants in mice overexpressing P2X7 receptors. Pretreatment of wild-type mice with LPS increased P2X7 receptor levels in the brain and reduced responsiveness to anticonvulsants during status epilepticus, which was overcome by either genetic deletion of P2X7 receptors or treatment with the P2X7 receptor antagonists, AFC-5128 or ITH15004. Conclusion and Implications: Our results demonstrate that P2X7 receptor-induced pro-inflammatory effects contribute to resistance to pharmacotherapy during status epilepticus. Therapies targeting P2X7 receptors could be novel adjunctive treatments for drug-refractory status epilepticus.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

A CANDLE for a deeper in-vivo insight

  • Coupé, Pierrick
  • Munz, Martin
  • Ruthazer, Edward S.
  • Collins, D. Louis
  • Manjón Herrera, José Vicente|||0000-0001-6640-927X
A new Collaborative Approach for eNhanced Denoising under Low-light Excitation (CANDLE) is introduced for the processing of 3D laser scanning multiphoton microscopy images. CANDLE is designed to be robust for low signal-to-noise ratio (SNR) conditions typically encountered when imaging deep in scattering biological specimens. Based on an optimized non-local means filter involving the comparison of filtered patches, CANDLE locally adapts the amount of smoothing in order to deal with the noise inhomogeneity inherent to laser scanning fluorescence microscopy images. An extensive validation on synthetic data, images acquired on microspheres and in vivo images is presented. These experiments show that the CANDLE filter obtained competitive results compared to a state-of-the-art method and a locally adaptive optimized non-local means filter, especially under low SNR conditions (PSNR < 8 dB). Finally, the deeper imaging capabilities enabled by the proposed filter are demonstrated on deep tissue in vivo images of neurons and fine axonal processes in the Xenopus tadpole brain., We want to thank Florian Luisier for providing free plugin of his PureDenoise filter. We also want to thank Markku Makitalo for providing the code of their OVST. This study was supported by the Canadian Institutes of Health Research (CIHR, MOP-84360 to DLC and MOP-77567 to ESR) and Cda (CECR)-Gevas-OE016. MM holds a fellowship from the Deutscher Akademischer Austasch Dienst (DAAD) and a McGill Principal's Award. ESR is a tier 2 Canada Research Chair. This work has been partially supported by the Spanish Health Institute Carlos III through the RETICS Combiomed, RD07/0067/2001. This work benefited from the use of ImageJ.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Characterization of Anisotropic Optical Behavior in Phase-Change Material Sb2Se3

  • Gutierrez, Yael
  • Juan, Dilson
  • Agresti, Filippo
  • Fernandez-Manteca, Maria Gabriela
  • Vazquez-Miranda, Saul
  • Espinoza, Shirly
  • Losurdo, Maria
  • López-Mulet, Iñigo|||0009-0006-9401-819X
  • Parra Gomez, Jorge|||0000-0003-4610-3411
  • Sanchis Kilders, Pablo|||0000-0003-2984-4218
[EN] Phase-change materials with ultralow optical losses are enabling a new generation of reconfigurable photonic devices. Sb2Se3 has emerged as a leading candidate owing to its negligible optical losses across the visible and infrared, yet how polycrystallinity translates into optical inhomogeneity in thin-film form remains largely unexplored. Here, the anisotropic optical response of thermally crystallized Sb2Se3 films is systematically characterized by combining imaging Mueller matrix polarimetry, spatially resolved spectroscopic ellipsometry, and many-body perturbation theory calculations. X-ray diffraction reveals a fiber texture with (0k0) planes preferentially parallel to the film surface, while (00l) and (h00) planes are randomly oriented in-plane. Polarimetric imaging exposes pronounced linear birefringence and dichroism at the domain scale, with in-plane contrasts of |Delta n| approximate to 0.5 and |Delta k| approximate to 0.5 at 633 nm. Spatially resolved ellipsometry quantifies a refractive-index contrast of Delta n = 0.13 between differently oriented crystallites at telecommunication wavelengths, sufficient to induce measurable phase errors in integrated photonic circuits. First-principles calculations reproduce the experimental dielectric functions quantitatively and establish the principal-axis ordering n(c) > n(a) > n(b). These results reveal that polycrystalline grain orientation is a critical, often overlooked source of optical inhomogeneity in Sb2Se3 films, with direct implications for the design of low-loss reconfigurable photonic devices., Y.G. acknowledges funding from a Ramon y Cajal Fellowship (RYC2022-037828-I) and the "Proyectos Puente 2025" programme of the Universidad de Cantabria, funded by the Government of Cantabria through the Contrato Programa Gobierno de Cantabria-UC (VQ16). Y.G. also acknowledge funding by ODAPtive Project (PID2025-169188NA-I00). The National Research Council of Italy (CNR) is gratefully acknowledged for co-funding the acquisition at ICMATE-CNR of an XRD and an XPS system in the frame of the "Roadmap per lo sviluppo delle infrastrutture e il Programma Biennale degli Interventi (delibera CdA 136/2020)". P.S. acknowledges funding from Agencia Estatal de Investigacion (PID2022-137787OB-I00 funded by MCIN/AEI/10.13039/501100011033/FEDER, UE). The authors acknowledge the fabrication team at the Nanophotonics Technology Center (Universitat Politecnica de Valencia, Spain) for the fabrication of the samples.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Simultaneous segmentation and grading of anatomical structures for patient&apos, s classification: application to Alzheimer&apos, s Disease

  • Coupé, Pierrick
  • Eskildsen, Simon F.
  • Fonov, Vladimir S.
  • Collins, D. Louis
  • Manjón Herrera, José Vicente|||0000-0001-6640-927X
  • Alzheimer&apos;s Dis Neuroimaging
In this paper, we propose an innovative approach to robustly and accurately detect Alzheimer's disease (AD) based on the distinction of specific atrophic patterns of anatomical structures such as hippocampus (HC) and entorhinal cortex (EC). The proposed method simultaneously performs segmentation and grading of structures to efficiently capture the anatomical alterations caused by AD. Known as SNIPE (Scoring by Non-local Image Patch Estimator), the novel proposed grading measure is based on a nonlocal patch-based frame-work and estimates the similarity of the patch surrounding the voxel under study with all the patches present in different training populations. In this study, the training library was composed of two populations: 50 cognitively normal subjects (CN) and 50 patients with AD, randomly selected from the ADNI database. During our experiments, the classification accuracy of patients (CN vs. AD) using several biomarkers was compared: HC and EC volumes, the grade of these structures and finally the combination of their volume and their grade. Tests were completed in a leave-one-out framework using discriminant analysis. First, we showed that biomarkers based on HC provide better classification accuracy than biomarkers based on EC. Second, we demonstrated that structure grading is a more powerful measure than structure volume to distinguish both populations with a classification accuracy of 90%. Finally, by adding the ages of subjects in order to better separate age-related structural changes from disease-related anatomical alterations, SNIPE obtained a classification accuracy of 93%, Data collection and sharing for this project were funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904). ADNI is funded by the National Insti- tute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: Abbott, AstraZeneca AB, Bayer Schering Pharma AG, Bristol-Myers Squibb, Eisai Global Clinical Development, Elan Corporation, Genentech, GE Healthcare, GlaxoSmithKline, Innogenetics, Johnson and Johnson, Eli Lilly and Co., Medpace, Inc., Merck and Co., Inc., Novartis AG, Pfizer Inc, F. Hoffman-La Roche, Schering-Plough, Synarc, Inc., as well as non-profit partners the Alzheimer's Association and Alzheimer's Drug Discovery Foundation, with participation from the U.S. Food and Drug Administration. Private sector contributions to ADNI are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of California, Los Angeles. This research was also supported by NIH grants P30AG010129, K01 AG030514, and the Dana Foundation.
Docta Complutense
Publication Artículo científico (JournalArticle)

P2X7 Receptor-Dependent microRNA Expression Profile in the Brain Following Status Epilepticus in Mice

  • Conte, Giorgia
  • Nguyen, Ngoc T.
  • Alves, Mariana
  • De Diego García, Laura
  • Kenny, Aidan
  • Nicke, Annette
  • Henshall, David C.
  • Jimenez-Mateos, Eva M.
  • Engel, Tobias
The ionotropic ATP-gated P2X7 receptor is an important contributor to inflammatory signaling cascades via the release of Interleukin-1b, as well as having roles in cell death, neuronal plasticity and the release of neurotransmitters. Accordingly, there is interest in targeting the P2X7 receptor for the treatment of epilepsy. However, the signaling pathways downstream of P2X7 receptor activation remain incompletely understood. Notably, recent studies showed that P2X7 receptor expression is controlled, in part, by microRNAs (miRNAs). Here, we explored P2X7 receptor-dependent microRNA expression by comparing microRNA expression profiles of wild-type (wt) and P2X7 receptor knockout mice before and after status epilepticus. Genome-wide microRNA profiling was performed using hippocampi from wt and P2X7 receptor knockout mice following status epilepticus induced by intra-amygdala kainic acid. This revealed that the genetic deletion of the P2X7 receptor results in distinct patterns of microRNA expression. Specifically, we found that in vehicle-injected control mice, the lack of the P2X7 receptor resulted in the up-regulation of 50 microRNAs and down-regulation of 35 microRNAs. Post-status epilepticus, P2X7 receptor deficiency led to the up-regulation of 44 microRNAs while 13 microRNAs were down-regulated. Moreover, there was only limited overlap among identified P2X7 receptor-dependent microRNAs between control conditions and post-status epilepticus, suggesting that the P2X7 receptor regulates the expression of different microRNAs during normal physiology and pathology. Bioinformatic analysis revealed that genes targeted by P2X7 receptor-dependent microRNAs were particularly overrepresented in pathways involved in intracellular signaling, inflammation, and cell death; processes that have been repeatedly associated with P2X7 receptor activation. Moreover, whereas genes involved in signaling pathways and inflammation were common among up- and down-regulated P2X7 receptor-dependent microRNAs during physiological and pathological conditions, genes associated with cell death seemed to be restricted to up-regulated microRNAs during both physiological conditions and post-status epilepticus. Taken together, our results demonstrate that the P2X7 receptor impacts on the expression profile of microRNAs in the brain, thereby possibly contributing to both the maintenance of normal cellular homeostasis and pathological processes.
Docta Complutense
Publication Artículo científico (JournalArticle)

Elevated blood purine levels as a biomarker of seizures and epilepsy

  • Beamer, Edward
  • Lacey, Austin
  • Alves, Mariana
  • Conte, Giorgia
  • Tian, Faming
  • De Diego García, Laura
  • Khalil, Mohamed
  • Rosenow, Felix
  • Delanty, Norman
  • Dale, Nicholas
  • El-Naggar, Hany
  • Henshall, DC
  • Engel, Tobias
Objective: There is a major unmet need for a molecular biomarker of seizures or epilepsy that lends itself to fast, affordable detection in an easy-to- use point-of-care device. Purines such as adenosine triphosphate and adenosine are potent neuromodulators released during excessive neuronal activity that are also present in biofluids. Their biomarker potential for seizures and epilepsy in peripheral blood has, however, not yet been investigated. The aim of the present study was to determine whether blood purine nucleoside measurements can serve as a biomarker for the recent occurrence of seizures and to support the diagnosis of epilepsy. Methods: Blood purine concentrations were measured via a point-of-care diagnostic technology based on the summated electrochemical detection of adenosine and adenosine breakdown products (inosine, hypoxanthine, and xanthine; SMARTChip). Measurements of blood purine concentrations were carried out using samples from mice subjected to intra-amygdala kainic acid-induced status epilepticus and in video-electroencephalogram (EEG)-monitored adult patients with epilepsy. Results: In mice, blood purine concentrations were rapidly increased approximately two-to threefold after status epilepticus (2.32 ± .40 μmol·L–1 [control] vs. 8.93 ± 1.03 μmol·L–1 [after status epilepticus]), and levels correlated with seizure burden and postseizure neurodegeneration in the hippocampus. Blood purine concentrations were also elevated in patients with video-EEG-diagnosed epilepsy (2.39 ± .34 μmol·L–1 [control, n = 13] s. 4.35 ± .38 μmol·L–1 [epilepsy, n = 26]). Significance: Our data provide proof of concept that the measurement of blood purine concentrations may offer a rapid, low-volume bedside test to support the diagnosis of seizures and epilepsy.